MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Continuous subcutaneous apomorphine infusion for the management of Parkinson’s disease at the end-of-life

    M. Bereau, M. Giffard, AL. Clairet, M. Verin, M. Auffret (Besançon, France)

    Objective: To describe the benefit of continuous subcutaneous apomorphine infusion (CSAI) for terminal care management in 7 PD patients. Background: There are currently no recommendations…
  • 2022 International Congress

    Childhood Trauma and Parkinson’s Disease: Associations of Adverse Childhood Experiences, Disease Severity and Quality of Life

    I. Subramanian, B. Mcdaniels, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: Objective: The goal of this study was to survey individuals with PD to evaluate whether intensity of childhood trauma is associated with individual symptoms,…
  • 2022 International Congress

    Trends in incidence of hospitalizations in Parkinson´s Disease in Spain (2010-2019)

    V. Gómez-Mayordomo, R. Jiménez-García, E. Sanesteban-Beceiro, E. López-Valdés, R. García-Ramos, F. Alonso-Frech (Madrid, Spain)

    Objective: To estimate the incidence of in-hospital admissions of Parkinson´s disease (PD) in Spain during the last decade (2010-2019) and describe the epidemiology of these…
  • 2022 International Congress

    What is the appropriate sleep position for Parkinson’s disease patients with orthostatic hypotension in the morning?

    T. Prasertpan, R. Chokesuwattanaskul, J. Sringean, S. Siwanogsatham, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To determine the effect of sleep positions on morning OH in PD patients Background: Orthostatic hypotension (OH) is considered one of the most disabling…
  • 2022 International Congress

    Diagnostic Accuracy of Parkinson’s disease: Where Do We Stand?

    S. Virameteekul (London, United Kingdom)

    Objective: To provide an up-to-date assessment of diagnostic accuracy parameters at early and late stages of the diagnosis in clinical practice and MDS Diagnostic Criteria…
  • 2022 International Congress

    DHDDS and NUS1: A converging pathway and common phenotype

    L. Williams, J. Qiu, S. Waller, N. Elserafy, M. Tchan, P. Procopis, H. Sampaio, S. Mohammad, H. Morales-Briceño, V. Fung (Sydney, Australia)

    Objective: To report on the clinical spectrum of variants affecting dehydrodolichol diphosphate synthetase (DHDDS) and nuclear undecaprenyl pyrophosphate Synthase 1 (NUS1) and particularly to highlight their…
  • 2022 International Congress

    An exploration of tic phenomenology in children with primary tic disorders

    C. Nilles, J. Fletcher, D. Martino, T. Pringsheim (Calgary, Canada)

    Objective: The aim of this study is to assess the phenomenology of tics in children with primary tic disorders and investigate how age and sex…
  • 2022 International Congress

    Effect of lower limb vs. abdominal compression on mobility in orthostatic hypotension – a single-blinded, randomized, controlled, cross-over study in Parkinson’s disease

    S. Paschen, C. Hansen, J. Welzel, J. Albrecht, A. Atresaei, K. Aminian, KE. Zeuner, R. Romijnders, E. Warmerdam, PP. Urban, D. Berg, W. Maetzler (Kiel, Germany)

    Objective: Orthostatic hypotension (OH) in Parkinson’s disease (PD) is frequent and associated with reduced quality of life and reduced activities of daily living. Abdominal binders…
  • 2022 International Congress

    Remote identification of early, sensor-based markers of Parkinson’s Disease using participants’ smartphones: The Parkinson Progression Marker Initiative Digital sub-study

    W. Popp, K. Taylor, T. Perumal, C. Tanner, A. Siderowf, L. Chahine, E. Brown, T. Simuni, T. Foroud, T. Kustermann, G. Pagano, H. Svoboda, M. Lindemann, K. Marek (Basel, Switzerland)

    Objective: To summarize the design of the Parkinson’s Progression Markers Initiative (PPMI) Digital sub-study. The study objective is to identify the earliest signs and symptoms…
  • 2022 International Congress

    Novel strategies based on sensory electrical stimulation to manage tremor in Parkinson’s disease. A pilot study.

    C. Montero Pardo, M. González Sánchez, A. Pascual Valdunciel, J. Sánchez Pérez, J. Camilo Moreno, F. Oliveira Barroso, F. Grandas, J. Luis Pons (Madrid, Spain)

    Objective: Tremor can be a disabling motor symptom in patients with Parkinson´s disease (PD) and in some patients is refractory to medication. Here we present…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley